Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
15 August 2019 | Story Xolisa Mnukwa | Photo Sonia Small
UFS debate
Join the UFS, University of Pretoria (UP) and the Motsepe Foundation in the upcoming Universities in Dialogue (UiD) conversation taking place on 20 August 2019.

Universities in Dialogue (UID) is an initiative driven by the Motsepe Foundation, which is aimed at promoting intergenerational, mixed-gender, and race conversations about socio-economic issues affecting South Africa. 

The purpose of the debate is to discuss alternative measures to advance gender equality and likeness across society, provide a platform for the youth to voice their concerns and deliberate in solution-driven conversation with renowned professors, and to create a space for students to collaborate among one another in order to solicit, drive, and fast-track transformation and nation-building in our country. 

According to research conducted by the Motsepe Foundation, the average age of the South African population is 26 years, which is why the initiative aims to generate debate among the youth on the most pressing concerns facing South Africa today. 

The foundation invited Kovsies to join the 2019 UiD dialogue, together with students and professors from the University of Pretoria (UP), the University of Cape Town (UCT), and Wits University. 

The dialogue/series is interlinked to the Motsepe Foundation Women’s Unit mandate, which aims to initiate interventions that will bring social, economic, and political empowerment to women and girls. The first debate, in partnership with the University of Pretoria, is scheduled for Women’s Month and will focus on the equal rights and participation of women.

The debate motion states: South Africa requires a feminist government to advance gender equity and equality across all sectors of society.

Event details are as follows:

Date: Tuesday, 20 August 2019
Time: 16:00–19:00

Venue: Access the dialogue live on 20 August 2019 here

For more information about the UiD, contact news@ufs.ac.za or call +27 51 401 9300 or +27 51 401 3735.





News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept